Graft Versus Host Disease (GVHD) – Highly Promising Therapies in Pipeline
According to the latest report of DelveInsight, “Graft Versus Host Disease (GVHD) - Market Insights, Epidemiology, and Market Forecast-2027,” in 2016, there were 9,847 and 9,006 cases of aGvHD and cGvHD, respectively, in 7 MM. - July 30, 2018
Lupus Nephritis - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - January 13, 2017
Acne Vulgaris - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight's report provides the market outlook of Acne Vulgaris. The major aim of the Report is to understand the market size of indication and market potential and future share of emerging drugs to understand the possible market opportunities in this sector. - January 11, 2017
DelveInsight Announces End of the Year Discount on Reports
DelveInsight, a leading market research and consulting company, is offering discounts on its market research reports. - November 25, 2016
Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight, the leading market research and consulting company, has added a new report, Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. - November 13, 2016
Graves’ Disease - Market Insights, Epidemiology and Market Forecast
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - October 30, 2016
Cushing's Syndrome - Market Insights, Epidemiology and Market Forecast
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - October 27, 2016
Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight, the leading market research and consulting company, has added a new report, Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. - October 15, 2016
Gastrointestinal Stromal Tumor - Market Insights, Epidemiology and Market Forecast
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - October 14, 2016
DelveInsight’s Launch of Its New & Improved Report Store
DelveInsight is delighted to announce the launch of its report store. The report store is collection of 3000+ analytical reports from the pharmaceutical as well as biotechnological industry. The store lets you browse through the vast collection of reports, gives you an overview of the different... - October 09, 2016
Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight, the leading market research and consulting company, has added a new report, Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. - October 09, 2016
Aspergillosis - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company, has added new report Aspergillosis - Pipeline Insights, 2016 to its portfolio. - September 17, 2016
Fibromyalgia - Market Insights, Epidemiology and Market Forecast - 2023
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - September 01, 2016
Endometrial Cancer- Market Insights, Epidemiology and Market Forecast - 2023
DelveInsight, the leading market research and consulting company, has added a new report Endometrial Cancer- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio. - August 28, 2016
Ewing’s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023
DelveInsight, the leading market research and consulting company, has added a new report Ewing’s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 to its portfolio. - August 21, 2016
T-Cell Lymphoma - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report T-Cell Lymphoma - Pipeline Insights, 2016 to its portfolio. - August 18, 2016
Gram Negative Bacterial Infections - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added the new report Gram Negative Bacterial Infections - Pipeline Insights, 2016 to its portfolio. - August 07, 2016
Bromodomain and Extra-Terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016 to its portfolio. - July 31, 2016
Phosphoinositide 3-Kinase (PI3k) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Phosphoinositide 3-Kinase (PI3k) Inhibitors – Pipeline Insights, 2016 to its portfolio. - July 24, 2016
Systemic Lupus Erythematosus (SLE) - Market Insights, Epidemiology and Market Forecast-2022
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - July 16, 2016
Natural Killer Cells - Competitive Landscape, Technology and Pipeline Analysis, 2016
The report provides information on the therapeutic development based on the Natural Killer Cells across 35+ pipeline drugs and 20+ companies active in this field. DelevInsight's Report also provides the comparative analysis of Natural Killer Cells at various stages of development like... - July 01, 2016
Diabetic Nephropathy - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Diabetic Nephropathy - Pipeline Insights, 2016 to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - June 23, 2016
Ovarian Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Ovarian Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - June 19, 2016
Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016 to its portfolio. - June 17, 2016
Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report, "Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016" to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. - June 02, 2016
Pancreatic Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 26, 2016
DelveInsight's Latest Release: Acute Ischemic Stroke - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report Acute Ischemic Stroke - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 17, 2016
Lysosomal Storage Disorder - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 14, 2016
Antibody Drug Conjugate Insight: Technology Trend, Pipeline Assessment and Competitive Landscape, 2016
DelveInsight has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its Portfolio. - May 14, 2016
Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020 - A DelveInsight Report
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. - May 12, 2016
Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. - May 11, 2016
Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - April 16, 2016
Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for... - April 13, 2016
Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 30, 2016
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 19, 2016
Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 18, 2016
Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 17, 2016
Multiple Myeloma - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 16, 2016
Stem Cell Oncology – Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - March 08, 2016
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 03, 2016
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 26, 2016
Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - February 25, 2016
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - February 25, 2016
PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 19, 2016
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology-based Indications & Mechanism of Action (MOA). - February 10, 2016
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016” to its portfolio. CAR-T cells are the next targeted agents in Oncology. CAR-T... - January 29, 2016
Pancreatic Cancer-Pipeline Insights, 2016- A DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients... - January 15, 2016
Peripheral Lung Cancer-Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Peripheral Lung Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients... - January 14, 2016
DelveInsight's Market Research Reports, 2016
DelveInsight has established its strong presence in therapeutic areas and has launched Analytical Reports on indication, mechanism of actions, drugs, Global API Manufacturers and specialized Reports on Gene Therapy, Anticoagulants, PD-1 and PDL-1, CART and Antibody Drug conjugates. After... - January 13, 2016